Activation mechanisms of matrix metalloproteinases

Biological Chemistry

Volumn 378, Issue 3-4, 1997, Pages 151-160

  Nagase, Hideaki ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Activation; Extracellular matrix; Matrix metalloproteinases; Matrixins; Proteinases; TIMPs

Indexed keywords

CELL ENZYME; CELL SURFACE PROTEIN; COLLAGENASE; CYSTEINE; ENZYME PRECURSOR; GELATINASE A; MATRIX METALLOPROTEINASE; METALLOPROTEINASE; PROTEINASE; STROMELYSIN;

ARTHRITIS; ATHEROSCLEROSIS; CANCER CELL; EMBRYO DEVELOPMENT; ENZYME ACTIVATION; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; GLOMERULONEPHRITIS; HUMAN; HUMAN CELL; METASTASIS; MORPHOGENESIS; PERIODONTITIS; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW; ULCER;

AMINO ACID SEQUENCE; ANIMALS; CYSTEINE; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; HUMANS; METALLOENDOPEPTIDASES; MOLECULAR SEQUENCE DATA;

EID: 0030957218     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Allan, J.A., Docherty, A.J., Barker, P.J., Huskisson, N.S., Reynolds, J.J., and Murphy, G. (1995). Binding of gelatinases A and B to type I collagen and other matrix components. Biochem. J. 309, 299-306.
2. Atkinson, S.J., Crabbe, T., Cowell, S., Ward, R.V., Butler, M.J., Sato, H., Seiki, M., Reynolds, J.J., and Murphy, G. (1995). Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes. J. Biol. Chem. 270, 30479-30485.
3. Basset, P., Belloca, J.R., Wolf, C., Stoll, I., Hatin, P., Limacher, J.M., Podhajcer, O.L., Chenard, M.P., Rio, M.C., and Chambon, P. (1990). A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348, 699-704.
4. Becker, J.W., Marcy, A.I., Rokosz, L.L., Axel, M.G., Burbaum, J.J., Fitzgerald, P.M.D., Cameron, P.M., Esser, C.K., Hagmann, W.K., Hermes, J.D., and Springer, J.P. (1995). Stromelysin-1: Three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme. Protein Science 4, 1966-1976.
5. Benbow, U., Butticè, G., Nagase, H., and Kurkinen, M. (1996). Characterization of the 46-kDa intermediates of matrix metalloproteinase 3 (stromelysin 1) obtained by site-directed mutation of phenylalanine 83. J. Biol. Chem. 271, 10715-10722.
6. Bode, W., Reinemer, P., Huber, R., Kleine, T., Schnierer, S., and Tschesche, H. (1994). The X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity. EMBO J. 13, 1263-1269.
7. r 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res. 50, 6184-6191.
8. Cameron, P.M., Marcy, A.I., Rokosz, L.L., and Hermes, J.D. (1995). Use of an active-site inhibitor of stromelysin to elucidate the mechanism of prostromelysin activation. Bioorg. Chem. 23, 415-426.
9. Chen, L.-C., Noelken, M.E., and Nagase, H. (1993). Disruption of the cysteine-75 and zinc ion coordination is not sufficient to activate the precursor of human matrix metalloproteinase 3 (stromelysin 1). Biochemistry 32, 10289-10295.
10. Cossins, J., Dudgeon, T.J., Catlin, G., Gearing, A.J.H., and Clements, J.M. (1996). Identification of MMP-18, a putative novel human matrix metalloproteinase. Biochem. Biophys. Res. Commun. 228, 494-498.
11. Crabbe, T., O'Connell, J., Smith, B.J., and Docherty, A.J.P. (1994a). Reciprocated matrix metalloproteinase activation: A process performed by interstitial collagenase and progelatinase A. Biochemistry 33, 14419-14425.
12. Crabbe, T., Smith, B., O'Connell, J., and Docherty, A. (1994b). Human progelatinase A can be activated by matrilysin. FEBS Lett. 345, 14-16.
13. DeClerck, Y.A., Yean, T.-D., Lu, H.S., Ting, J., and Langley, K.E. (1991). Inhibition of autoproteolytic activation of interstitial procollagenase by recombinant metalloproteinase inhibitor MI/TIMP-2. J. Biol. Chem. 266, 3892-3899.
14. Ellis, V., Behrendt, N., and Dano, K. (1991). Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor. J. Biol. Chem. 266, 12752-12758.
15. Ellis, V., Pyke, C., Eriksen, J., Solberg, H., and Dano, K. (1992). The urokinase receptor: Involvement in cell surface proteolysis and cancer invasion. Ann. N.Y. Acad. Sci. 667, 13-31.
16. Freimark, B.D., Feeser, W.S., and Rosenfeld, S.A. (1994). Multiple sites of the propeptide region of human stromelysin-1 are required for maintaining a latent form of the enzyme. J. Biol. Chem. 269, 26982-26987.
17. Fridman, R., Toth, M., Peña, D., and Mobashery, S. (1995). Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res. 55, 2548-2555.
18. Galazka, G., Windsor, L.J., Birkedal-Hansen, H., and Engler, J.A. (1996). APMA (4-aminophenylmercuric acetate) activation of stromelysin-1 involves protein interactions in addition to those with cysteine-75 in the propeptide. Biochemistry 35, 11221-11227.
19. Goldberg, G.I., Strongin, A., Collier, I.E., Genrich, L.T., and Marmer, B.L. (1992). Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J. Biol. Chem. 267, 4583-4591.
20. Holz, R.C., Salowe, S.P., Smith, C.K., Cuca, G.C., and Que, L. Jr. (1992). EXAFS evidence for a 'cysteine switch' in the activation of prostromelysin. J. Am. Chem. Soc. 114, 9611-9614.
21. Imai, K., Yokohama, Y., Nakanishi, I., Ohuchi, E., Fujii, Y., Nakai, N., and Okada, Y. (1995). Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties. J. Biol. Chem. 270, 6691-6697.
22. Itoh, Y., and Nagase, H. (1995). Preferential inactivation of tissue inhibitor of metalloproteinases-1 that is bound to the precursor of matrix metalloproteinase 9 (progelatinase B) by human neutrophil elastase. J. Biol. Chem. 270, 16518-16521.
23. Itoh, Y., Binner S., and Nagase, H. (1995). Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate. Biochem. J. 308, 645-651.
24. Knäuper, V., Wilhelm, S.M., Seperack, P.K., DeClerck, Y.A., Langle, K.E., Osthues, A., and Tschesche, H. (1993). Direct activation of human neutrophil procollagenase by recombinant stromelysin. Biochem. J. 295, 581-586.
25. Knäuper, V., Murphy, G., and Tschesche, H. (1996a). Activation of human neutrophil procollagenase by stromelysin 2. Eur. J. Biochem. 235, 187-191.
26. Knäuper, V., Will, H., López-Otín, C., Smith, B., Atkinson, S.J., Stanton, H., Hembry, R.M., and Murphy, G. (1996b). Cellular mechanisms for human procollagenase-3 (MMP-13) activation. J. Biol. Chem. 271, 17124-17131.
27. r active forms, and a comparison of recombinant with natural stromelysin activities. Biochem. J. 276, 217-221.
28. Kolkenbrock, H., Orgel, D., Hecker-Kia, A., Noack, W., and Ulbrich, N. (1991). The complex between a tissue inhibitor of metalloproteinases (TIMP-2) and 72-kDa progelatinase is a metalloproteinase inhibitor. Eur. J. Biochem. 198, 775-781.
29. Kolkenbrock, H., Hecker-Kia, A., Orgel, D., Rappitsch, W., and Ulbrich, N. (1994). Activity of ternary gelatinase A-TIMP-2-matrix metalloproteinase complexes. Biol. Chem. Hoppe-Seyler 375, 589-595.
30. Uchte, A., Kolkenbrock, H., and Tschesche, H. (1996). The recombinant catalytic domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) induces activation of progelatinase A and progelatinase A complexed with TIMP-2. FEBS Lett. 397, 277-282.
31. Murphy, G., Allan, J.A., Willenbrock, F., Cockett, M.I., O'Connell, J.P., and Docherty, A.J.P. (1992a). The role of the C-terminal domain in collagenase and stromelysin specificity. J. Biol. Chem. 267, 9612-9618.
32. Murphy, G., Willenbrock, F., Ward, R.V., Cockett, M.I., Eaton, D., and Docherty, A.J. (1992b). The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases. Biochem. J. 283, 637-641.
33. Nagase, H., Enghild, J.J., Suzuki, K., and Salvesen, G. (1990). Stepwise activation of mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl) mercuric acetate. Biochemistry 29, 5783-5789.
34. Nagase, H. (1996). Matrix Metalloproteinases. In: Zinc Metalloproteinases in Health and Disease, N.M. Hooper, ed. (London, England: Taylor and Francis), pp. 153-204.
35. Nagase, H., and Okada, Y. (1996). Proteinases and matrix degradation. In: The Textbook of Rheumatology (5th Edition), W.N. Kelley, E.D. Harris, Jr., S. Ruddy, C.B. Sledge, eds. (Philadelphia, PA, USA: W.B. Saunders Co.), pp. 323-341.
36. Nomura, H., Sato, H., Seiki, M., Mai, M., and Okada, Y. (1995). Expression of membrane-type matrix metalloproteinase in human gastric carcinomas. Cancer Res. 55, 3263-3266.
37. Ogata, Y., Enghild, J.J., and Nagase, H. (1992). Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J. Bio. Chem. 267, 3581-3584.
38. Ogata, Y., Itoh, Y., and Nagase, H. (1995). Steps involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinases-1 complex by 4-aminophenylmercuric acetate and proteinases. J. Biol. Chem. 270, 18506-18511.
39. Ohuchi, E., Imai, K., Fujii, Y., Sato, H., Seiki, M., and Okada, Y. (1997). Membrane type I matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J. Biol. Chem. 272, 2446-2451.
40. Okada, Y., Harris, E.D., Jr., and Nagase, H. (1988). The precursor of a metalloendopeptidase from human rheumatoid synovial fibroblasts. Purification and mechanisms of activation by endopeptidases and 4-aminophenylmercuric acetate. Biochem. J. 254, 731-741.
41. Okada, Y., Morodomi, T., Enghild, J.J., Suzuki, K., Yasui, A., Nakanishi, I., Salvesen, G., and Nagase, H. (1990). Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties. Eur. J. Biochem. 194, 721-730.
42. Okada, Y., Gonoji, Y., Naka, K., Tomita, K., Nakanishi, I., Iwata, K., Yamashita, K., and Hayakawa, T. (1992). Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J. Biol. Chem. 267, 21712-21719.
43. Overall, C.M., and Sodek, J. (1990). Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. Induction and endogenous activation of collagenase, 72-kDa gelatinase, and Pump-1 is accompanied by the suppression of the tissue inhibitor of matrix metalloproteinases. J. Biol. Chem. 265, 21141-21151.
44. Pei, D., and Weiss, S.J. (1995). Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 375, 244-247.
45. Pei, D., and Weiss, S.J. (1996). Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J. Biol. Chem. 271, 9135-9140.
46. Poulsom, R., Pignatelli, M., Stetler-Stevenson, W.G., Liotta, L.A., Wright, P.A., and Jeffery, R.E. (1992). Stromal expression of 72 kDa type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. Am. J. Pathol. 141, 389-396.
47. Puente, X.S., Pendás, A.M., Llano, E., Velasco, G., and López-Otín, C. (1996). Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res. 56, 944-949.
48. Reinemer, P., Grams, F., Huber, R., Kleine, T., Schnierer, S., Piper, M., Tschesche, H., and Bode, W. (1994). Structural implications for the role of the N-terminus in the 'superactivation' of collagenases. A crystallographic study. FEBS Lett. 338, 227-233.
49. 84 bond by mast cell chymase. J. Biol. Chem. 269, 18134-18140.
50. Saksela, O., and Rifkin, D.B. (1988). Cell-associated plasminogen activation: Regulation and physiological functions. Annu. Rev. Cell. Biol. 4, 93-126.
51. Salowe, S.P., Marcy, A.I., Cuca, G.C., Smith, C.K., Kopka, I.E., Hagmann, W.K., and Hermes, J.D. (1992). Characterization of zinc-binding sites in human stromelysin-1: stoichiometry of the catalytic domain and identification of a cysteine ligand in the proenzyme. Biochemistry 31, 4535-4540.
52. Sang, Q.A., Bodden, M.K., and Windsor, L.J. (1996). Activation of human progelatinase A by collagenase and matrilysin: Activation of procollagenase by matrilysin. J. Pro. Chem. 15, 243-253.
53. Sang, Q.-X., Birkedal-Hansen, H., and Van Wart, H.E. (1995). Proteolytic and non-proteolytic activation of human neutrophil progelatinase B. Biochim. Biophys. Acta 1251, 99-108.
54. Santavicca, M., Noel, A., Angliker, H., Stoll, I., Segain, J.-P., Anglard, P., Chretien, M., Seidah, N., and Bassett, P. (1996). Characterization of structural determinants and molecular mechanisms involved in pro-stromelysin-3 activation by 4-aminophenylmercuric acetate and furin-type convertases. Biochemistry J. 315, 953-958.
55. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., and Seiki, M. (1994). A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370, 61-65.
56. Sato, H., Kinoshita, T., Takino, T., Nakayama, K., and Seiki, M. (1996). Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett. 393, 101-104.
57. 73 active-site zinc complex in latency and a 'cysteine switch' mechanism for activation. Proc. Natl. Acad. Sci. USA 87, 364-368.
58. Steffensen, B., Wallon, U.M., and Overall, C.M. (1995). Extracellular matrix binding properties of recombinant fibronectin type II-like modules of human 72-kDa gelatinase/type IV collagenase. High affinity binding to native type I collagen but not native type IV collagen. J. Biol. Chem. 270, 11555-11566.
59. Stetler-Stevenson, W.G., Krutzsch, H.C., and Liotta, L.A. (1989). Tissue inhibitors of metalloproteinase (TIMP-2): a new member of the metalloproteinase inhibitor family. J. Biol. Chem. 264, 17374-17378.
60. Stolow, M., Bauzon, D.D., Li, J., Sedgwick, T., Liang, V.C.-T., Sang, Q.A., and Shi, Y. (1996). Identification and characterization of a novel collagenase in Xenopus laevis: possible roles during frog development. Mol. Biol. Cell 7, 1471-1483.
61. Strongin, A.Y., Marmer, B.L., Grant, G.A., and Goldberg, G.I. (1993). Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2. J. Biol. Chem. 268, 14033-14039.
62. Strongin, A.Y., Collier, I., Bannikov, G., Marmer, B.L., Grant, G.A., and Goldberg, G.I. (1995). Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J. Biol. Chem. 270, 5331-5338.
63. Suzuki, K., Enghild, J.J., Morodomi, T., Salvesen, G., and Nagase, H. (1990). Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin). Biochemistry 29, 10261-10270.
64. Suzuki, K., Lees, M., Newlands, G.F.J., Nagase, H., and Woolley, D.E. (1995). Activation of precursors for matrix metalloproteinases 1 (interstitial collagenase) and 3 (stromelysin) by rat mast-cell proteinases I and II. Biochem. J. 305, 301-306.
65. Takino, T., Sato, H., Shinagawa, A., and Seiki, M. (1995). Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. MT-MMPs form a unique membrane-type subclass in the MMP family. J. Biol. Chem. 270, 23013-23020.
66. Van Wart, H.E., and Birkedal-Hansen, H. (1990). The cysteine switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc. Natl. Acad. Sci. USA 87, 5578-5582.
67. Ward, R.V., Atkinson, S.J., Slocombe, P.M., Docherty, A.J.P., Reynolds, J.J., and Murphy, G. (1991a). Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes. Biochim. Biophys. Acta 1079, 242-246.
68. Ward, R.V., Hembry, R.H., Reynolds, J.J., and Murphy, G. (1991b). The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex. Biochem. J. 278, 179-187.
69. Ward, R.V., Atkinson, S.J., Reynolds, J.J., and Murphy, G. (1994). Cell surface-mediated activation of progelatinase A: demonstration of the involvement of the C-terminal domain of progelatinase A in cell surface binding and activation of progelatinase A by primary fibroblasts. Biochem. J. 304, 263-269.
70. Wilhelm, S.M., Collier, I.E., Marmer, B.L., Eisen, A.Z., Grant, G.A., and Goldberg, G.I. (1989). SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J. Biol. Chem. 264, 17213-17221.
71. Will, H., and Hinzmann, B. (1995). cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. Eur. J. Biochem. 231, 602-608.
72. Will, H., Atkinson, S.J., Butler, G.S., Smith, B., and Murphy, G. (1996). The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. J. Biol. Chem. 271, 17119-17123.
73. Woessner, J.F., Jr. (1994). The family of matrix metalloproteinases. Ann. N.Y. Acad. Sci. 732, 11-21.